Anti-MR-proADM Antibody, clone 2B19 ZooMAb^® Rabbit Monoclonal

rabbit

200

expressed in HEK 293 cells

unconjugated

purified antibody

primary antibodies

2B19, monoclonal
recombinant monoclonal

ZooMAb^® learn more

lyophilized

calculated mol wt ~ 20.42 kDa
observed mol wt ~ 20 kDa

human

antibody small pack of 25 μL

recombinant expression
Learn more about Antibody Enhanced Validation

affinity binding assay: suitable
immunohistochemistry (formalin-fixed, paraffin-embedded sections): suitable
western blot: suitable

IgG

ambient

2-8℃

ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.

Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.

Clone 2B19 is a ZooMAb^® rabbit recombinant monoclonal antibody that specifically detects human ADM. It targets an epitope within the mid-region (MR) of ADM.

KLH-conjugated linear peptide corresponding to 24 amino acids from the propeptide N-terminal half of human ADM.

Quality Control Testing

Evaluated by Western Blotting with recombinant Human ADM Protein.

Western Blotting Analysis: A 1:1,000 dilution of this antibody detected recombinant human ADM protein.

Tested Applications

Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected MR-proADM in human placenta tissue sections.

Affinity Binding Assay: A representative lot of this antibody bound MR-proADM peptide with a KD of 9.9 x 10-7 in an affinity binding assay.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Anti-MR-proADM, clone 2B19 ZooMAb^®, Cat. No. ZRB1182, is a recombinant Rabbit monoclonal antibody that specifically targets MR-proADM and is tested for use in Affinity Binding Assay, Immunohistochemistry (Paraffin), and Western Blotting.

Purified recombinant mouse monoclonal antibody IgG, lyophilized in PBS, 5% Trehalose, normal appearance a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.

300 μg/mL after reconstitution at 25 μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

pro-ADM (UniProt: P35318; also known as Mid-regional pro-adrenomedullin) is encoded by the ADM (also known as AM) gene (Gene ID: 133) in human. ADM is synthesized with a signal peptide (aa 1-21) and is cleaved into Adrenomedullin (AM; aa 95-146) and Proadrenomedullin N-20 terminal peptide (PAMP; aa 21-41). AM and PAMP serve as potent hypotensive and vasodilatory agents involved in physiologic control of fluid and electrolyte homeostasis. In the kidney, AM acts as a diuretic and natriuretic, and both AM and PAMP are known to inhibit aldosterone secretion. ADM contains a region known as mid-region ProADM (aa 45-92) that lacks any activity but is a reliable biomarker for sepsis and progression to septic shock. ADM has been found in all epithelial surfaces that separate the internal and external environment, such as integument, respiratory, digestive and genito-urinary tract. It is also found in all bodily secretions and imparts protection against external pathogens. Its highest levels are reported in pheochromocytoma and adrenal medulla. ADM as well as PAMP also display potent antimicrobial action against both Gram-positive and Gram-negative bacteria. MR-proADM, a fragment of 48 amino acids that splits from the proADM and is present in a ratio of 1:1 with ADM, proportionally represents the levels and activity of ADM. This ZooMAb^® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Onal, U., et al. (2018). Healthcare (Basel). 6(3); 110; Valenzuela-Sanchez, F., et al. (2016). Ann. Transl. Med. 4(17); 329).

Recommend storage of lyophilized product at 2-8℃; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8℃, or -20℃ for long term storage. Avoid repeated freeze-thaws.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

11 - Combustible Solids

WGK 1